Xu SG - Search Results

1

Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma.

Li FJ, Gao LC, Long HZ, Zhou ZW, Luo HY, Xu SG, Dai SM, Hu JD. Li FJ, et al. Among authors: xu sg. J Pharm Pharmacol. 2024 Jul 23:rgae085. doi: 10.1093/jpp/rgae085. Online ahead of print. J Pharm Pharmacol. 2024. PMID: 39045884

2

Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways.

Zhou ZW, Long HZ, Xu SG, Li FJ, Cheng Y, Luo HY, Gao LC. Zhou ZW, et al. Among authors: xu sg. Front Pharmacol. 2022 May 13;13:899208. doi: 10.3389/fphar.2022.899208. eCollection 2022. Front Pharmacol. 2022. PMID: 35645817 Free PMC article. Review.

3

The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Long HZ, Zhou ZW, Cheng Y, Luo HY, Li FJ, Xu SG, Gao LC. Long HZ, et al. Among authors: xu sg. Front Aging Neurosci. 2022 Jun 30;14:888989. doi: 10.3389/fnagi.2022.888989. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35847685 Free PMC article. Review.

4

Pharmacokinetics, Bioequivalence, and Safety of 2 Formulations of Hydroxychloroquine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Luo HY, Long HZ, Zhou ZW, Xu SG, Li FJ, Cheng Y, Wen DD, Deng P, Gao LC. Luo HY, et al. Among authors: xu sg. Clin Pharmacol Drug Dev. 2023 Mar;12(3):273-278. doi: 10.1002/cpdd.1166. Epub 2022 Sep 1. Clin Pharmacol Drug Dev. 2023. PMID: 36047047 Clinical Trial.

5

System X_c ^-/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Li FJ, et al. Among authors: xu sg. Front Pharmacol. 2022 Aug 29;13:910292. doi: 10.3389/fphar.2022.910292. eCollection 2022. Front Pharmacol. 2022. PMID: 36105219 Free PMC article. Review.

6

Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.

Luo HY, Long HZ, Zhou ZW, Xu SG, Li FJ, Cheng Y, Wen DD, Deng P, Gao LC. Luo HY, et al. Among authors: xu sg. Drugs R D. 2022 Dec;22(4):311-320. doi: 10.1007/s40268-022-00406-2. Epub 2022 Nov 11. Drugs R D. 2022. PMID: 36369609 Free PMC article. Clinical Trial.

7

Relationship between miRNA and ferroptosis in tumors.

Dai SM, Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Dai SM, et al. Among authors: xu sg. Front Pharmacol. 2022 Nov 4;13:977062. doi: 10.3389/fphar.2022.977062. eCollection 2022. Front Pharmacol. 2022. PMID: 36408273 Free PMC article. Review.

8

Pharmacokinetics, safety, and bioequivalence of apixaban tablets in healthy Chinese subjects under fasting and fed conditions.

Luo HY, Yao ZJ, Long HZ, Zhou ZW, Xu SG, Li FJ, Cheng Y, Wen DD, Deng P, Guan YQ, Gao LC. Luo HY, et al. Among authors: xu sg. Int J Clin Pharmacol Ther. 2023 Mar;61(3):129-138. doi: 10.5414/CP204299. Int J Clin Pharmacol Ther. 2023. PMID: 36458443 Clinical Trial.

9

Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.

Luo HY, Gao LC, Long HZ, Zhou ZW, Xu SG, Li FJ, Li HL, Cheng Y, Li CX, Peng XY, Li L, Chen R, Deng P. Luo HY, et al. Among authors: xu sg. Eur J Clin Pharmacol. 2023 May;79(5):663-670. doi: 10.1007/s00228-023-03484-6. Epub 2023 Mar 28. Eur J Clin Pharmacol. 2023. PMID: 36976322

10

The important role of miR-1-3p in cancers.

Dai S, Li F, Xu S, Hu J, Gao L. Dai S, et al. J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8. J Transl Med. 2023. PMID: 37907984 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters